Alexion and Aide Health launch app for people with rare diseases
More than 3.5 million people in the UK live with a rare condition
Read More
Oct 9, 2026 | Healthcare, News
More than 3.5 million people in the UK live with a rare condition
Read MoreThe annual awards recognise excellence across 15 categories spanning innovation, manufacturing, sustainability and leadership
Read MoreThe results for litifilimab support the potential to achieve rapid and durable improvements in skin disease activity
Read MoreOct 8, 2026 | Healthcare, News
An estimated two million people in the UK are living with undiagnosed chronic obstructive pulmonary disease
Read MoreThis builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments
Read MoreThe deal will expand Shionogi’s growing portfolio with IntraBio’s rare diseases capabilities
Read MoreOct 5, 2026 | Healthcare, News
The new global awareness initiative calls for greater recognition, understanding and support for people living with chronic hand eczema
Read MoreOct 2, 2026 | News
Up to 91% of patients achieved at least 75% improvement in eczema severity and up to 67% achieved near-complete skin clearance
Read MoreOct 1, 2026 | News
Tulisokibart was designed to help address immuno-fibrosis, a key driver of disease progression in HS
Read MoreSep 30, 2026 | News, Regulatory
If approved, this treatment would offer a new option for the nearly one million Americans living with MS
Read MoreSep 29, 2026 | News, Regulatory
Desmoid tumours are rare soft tissue tumours that can grow aggressively into nearby tissues
Read MoreSep 28, 2026 | News, Regulatory
Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes
Read More
